Evidence map›Paper›PMID 40295029›Full record

ArticleIn vivo (Athens, Greece)

Validation of the Chick Chorioallantoic Membrane (CAM) Model for Biocompatibility Analysis of Biomaterials in the Context of the 3R-cascade: A Pilot Study.

Mike Barbeck, Kerstin Huebner, Kim Burkhardt, Tonya Andreeva, Rumen Krastev, Reiner Schnettler, Sanja Stojanovic, Stevo Najman, Ole Jung, Regine Schneider-Stock

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mike BarbeckClinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany; mike.barbeck@med.uni-rostock.de.
Kerstin HuebnerExperimental Tumor Pathology, Institute of Pathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Kim BurkhardtClinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.
Tonya AndreevaFaculty for Applied Chemistry, Reutlingen University, Reutlingen, Germany.
Rumen KrastevFaculty for Applied Chemistry, Reutlingen University, Reutlingen, Germany.
Reiner SchnettlerUniversity Medical Centre, Justus Liebig University of Giessen, Giessen, Germany.
Sanja StojanovicDepartment for Cell and Tissue Engineering, Scientific Research Center for Biomedicine, Faculty of Medicine, University of Niš, Niš, Serbia.
Stevo NajmanDepartment for Cell and Tissue Engineering, Scientific Research Center for Biomedicine, Faculty of Medicine, University of Niš, Niš, Serbia.
Ole JungClinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany.
Regine Schneider-StockExperimental Tumor Pathology, Institute of Pathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe present study aimed to compare the tissue responses to biomaterials in the chick chorioallantoic membrane (CAM) model with those from the subcutaneous implantation model in rats at an early time point. It was especially investigated whether histopathological scoring according to DIN EN ISO 10993-6 is also possible after biomaterial implantation using the CAM model and to what extent the values differ from the data obtained from small animal experiments. MATERIALS AND

methodsImplantation of a xenogeneic bone substitute using the CAM model for 24 h and subcutaneous implantation model in rats up to 10 days post implantation were conducted. Standardized histological and histopathological methods were used to apply for histopathological scoring according to DIN EN ISO 10993-6.

resultsThe histological analysis as well as the histo-pathological scoring revealed that the tissue responses to the xenogeneic bone substitute were completely comparable in both organisms with no visible or statistical differences.

conclusionWe suggest that bioincompatible biomaterials can already be sorted out in the context of THE preclinical

Indexed as

Biocompatible MaterialsBone SubstitutesChorioallantoic MembraneMaterials TestingAnimalsChick EmbryoChickensPilot ProjectsRatsBiocompatible MaterialsBone Substitutes3R-conceptBiocompatibilitybiomaterialchicken chorioallantoic membrane (CAM)DIN ISO 10993-6histopathologymedical devicescoring

Identifiers

PMID40295029
PMCPMC12041968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.